| 67184-0571-1 |
67184-0571 |
HUMAN PRESCRIPTION DRUG |
Mirabegron |
mirabegron |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20250630 |
N/A |
ANDA |
ANDA217989 |
Qilu Pharmaceutical Co., Ltd. |
MIRABEGRON |
25 mg/1 |
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0571-1) |
| 67184-0571-2 |
67184-0571 |
HUMAN PRESCRIPTION DRUG |
Mirabegron |
mirabegron |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20250630 |
N/A |
ANDA |
ANDA217989 |
Qilu Pharmaceutical Co., Ltd. |
MIRABEGRON |
25 mg/1 |
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0571-2) |
| 67184-0572-1 |
67184-0572 |
HUMAN PRESCRIPTION DRUG |
Mirabgeorn |
mirabegron |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20250630 |
N/A |
ANDA |
ANDA217989 |
Qilu Pharmaceutical Co., Ltd. |
MIRABEGRON |
50 mg/1 |
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-1) |
| 67184-0572-2 |
67184-0572 |
HUMAN PRESCRIPTION DRUG |
Mirabgeorn |
mirabegron |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20250630 |
N/A |
ANDA |
ANDA217989 |
Qilu Pharmaceutical Co., Ltd. |
MIRABEGRON |
50 mg/1 |
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-2) |